Company intelligence / Profile preview

Future Group

Ownership: Private
Development stage: Other

Overview

Future Pharmaceutical Company is an internationally recognized biotech leader providing integrated life sciences solutions including gene synthesis, peptide/protein/antibody production, biochemicals, insulin, vaccines, and preclinical drug development. The company supports genomic/proteomic research as well as pharmaceutical development for both human and animal health. No clinical trial results or marketed drugs are specified.

Modalities: Small moleculePeptideProteinAntibody
Industry: Biotech

Beyond the preview

Go deeper on Future Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Future Group.

Explore the full profile